Código QR (código de barras bidimensional)

Outcome of People with Parkinson’s Disease Treated with Levodopa-Entacapone-Carbidopa Intestinal Gel Who Failed Previous Subcutaneous Foslevodopa/Foscarbidopa

<b>Introduction:</b> The clinical outcome of switching to levodopa-entacapone-carbidopa intestinal gel (LECIG) after failure of subcutaneous foslevodopa/foscarbidopa (fLD/fCD) is unknown. We analyze it in people with Parkinson’s disease (PwP) treated in Spain. <b>Methods:</b> Retrospective analysis...

Fuld beskrivelse

Na minha lista:
Principais autores: Diego Santos García, Inés Legarda, Tamara M. González Fernández, Ana Rodríguez Sanz, Maria Isabel Morales-Casado, Alejandro Peral, Nuria Caballol, María Álvarez Sauco, Iria Campos Rodríguez, Déborah Alonso Modino, Lydia López Manzanares, Jesús Olivares Romero, Alberto Blanco Ollero
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2026-03-01
Serier:Brain Sciences
Fag:
effectiveness
foslevodopa/foscarbidopa
levodopa-entacapone-carbidopa
Parkinson’s disease
safety
Online adgang:https://www.mdpi.com/2076-3425/16/3/343
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker